<DOC>
	<DOCNO>NCT02605902</DOCNO>
	<brief_summary>Gilles da la Tourette syndrome ( TS ) * common chronic neuropsychiatric disorder characterize motor vocal tic . In adult patient , quality life significantly impair . TS , therefore , cost-intensive disease ( Germany : mean total costs=€3404/year ) . Despite significant adverse effect , dopamine receptor antagonist recommend first choice treatment many year . Although efficacy could demonstrate recently , today , behavioral therapy face-to-face Comprehensive Behavioral Intervention Tics ( CBIT ) ( include psychoeducation , habit reversal training , function-based assessment intervention , relaxation training ) recommend first line treatment tic . In Germany , however , dissemination CBIT restrict due considerable lack well-trained therapist . The aim study overcome deficiency create new sophisticated internet-delivered CBIT ( iCBIT ) program . In addition , internet-delivered CBIT shorten wait time , reach additional group patient - develop establish - highly cost-effective ( € 100 vs. € 1450 face-to-face CBIT ) . Investigators want perform multicenter , randomize , control , observer-blind trial include 160 adult patient order demonstrate 8 session ( 10 week ) iCBIT superior internet-delivered psychoeducation/relaxation adult patient TS . Both immediate ( 1 week end treatment ) long-term effect ( 3 6 month ) evaluate .</brief_summary>
	<brief_title>Trial Demonstrate Efficacy Safety Internet-delivered Behavioral Treatment Adults With Tic Disorders</brief_title>
	<detailed_description />
	<mesh_term>Tourette Syndrome</mesh_term>
	<mesh_term>Tic Disorders</mesh_term>
	<mesh_term>Tics</mesh_term>
	<criteria>Chronic tic disorder Tourette syndrome accord DSM5 Age ≥18 year ; Yale Global Tic Severity Scale ( YGTSS ) total tic score ( TTS ) &gt; 14 &gt; 10 ( patient motor vocal tic ) Clinical Global ImpressionSeverity Score ( CGIS ) &gt; 4 Medication tic comorbidities must stable dose least 6 week enter study Fluent German speak write Ability give inform consent sign informed consent History schizophrenia pervasive developmental disorder Comorbid obsessivecompulsive disorder ( OCD ) , attention deficit hyperactivity disorder ( ADHD ) , depression , anxiety disorder unstable and/or need initial adjustment therapy History behavioral treatment tic Current illicit substance abuse addiction ( clinically diagnose ) Secondary tic disorder significant neurological psychiatric disease No internet access ability use internet Participation study medicinal product device allow within 6 week inclusion concurrent study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Chronic tic disorder</keyword>
	<keyword>Tourette syndrome</keyword>
</DOC>